Willis Lease Finance (NASDAQ:WLFC – Get Free Report) and Capstone Therapeutics (NASDAQ:CAPS – Get Free Report) are both small-cap industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.
Profitability
This table compares Willis Lease Finance and Capstone Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Willis Lease Finance | 9.38% | 11.89% | 2.20% |
| Capstone Therapeutics | -31.00% | -167.41% | -38.24% |
Institutional and Insider Ownership
93.7% of Willis Lease Finance shares are owned by institutional investors. Comparatively, 2.5% of Capstone Therapeutics shares are owned by institutional investors. 56.4% of Willis Lease Finance shares are owned by insiders. Comparatively, 39.3% of Capstone Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares Willis Lease Finance and Capstone Therapeutics”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Willis Lease Finance | $828.30 million | 1.26 | $113.76 million | $3.37 | 13.54 |
| Capstone Therapeutics | $48.11 million | 0.03 | -$21.23 million | ($91.37) | -0.02 |
Willis Lease Finance has higher revenue and earnings than Capstone Therapeutics. Capstone Therapeutics is trading at a lower price-to-earnings ratio than Willis Lease Finance, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Willis Lease Finance and Capstone Therapeutics, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Willis Lease Finance | 1 | 1 | 1 | 1 | 2.50 |
| Capstone Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
Willis Lease Finance currently has a consensus price target of $75.50, indicating a potential upside of 65.44%. Given Willis Lease Finance’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Willis Lease Finance is more favorable than Capstone Therapeutics.
Risk and Volatility
Willis Lease Finance has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Comparatively, Capstone Therapeutics has a beta of -1.35, meaning that its share price is 235% less volatile than the S&P 500.
Summary
Willis Lease Finance beats Capstone Therapeutics on 15 of the 15 factors compared between the two stocks.
About Willis Lease Finance
Willis Lease Finance Corporation is an aviation services company specializing in the leasing and servicing of commercial aircraft engines. Founded in 1985, the company provides engines and related equipment to airlines, aircraft operators and maintenance providers. Its activities include leasing aircraft engines and auxiliary power units, trading engines and parts, and providing aviation maintenance and repair services. Willis Lease Finance also manages engine and equipment portfolios for customers.
About Capstone Therapeutics
Capstone Therapeutics Corporation was a biotechnology company focused on developing peptide-based therapeutics for tissue repair and regenerative medicine. Its research programs centered on synthetic peptides designed to influence healing and recovery in areas such as bone, soft tissue and cardiovascular injury. The company’s principal historical programs included Chrysalin (TP508), an experimental peptide derived from a portion of the human thrombin protein that was investigated for applications in bone and tissue healing, and AZX100, a peptide-based candidate studied for its potential to reduce fibrosis and postsurgical scarring.
Receive News & Ratings for Willis Lease Finance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willis Lease Finance and related companies with MarketBeat.com's FREE daily email newsletter.
